The prevalence of rheumatoid arthritis in Spain.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 12 2020
Historique:
received: 13 07 2020
accepted: 28 10 2020
entrez: 10 12 2020
pubmed: 11 12 2020
medline: 1 5 2021
Statut: epublish

Résumé

Rheumatoid arthritis (RA) prevalence is believed to be around 1% worldwide, although it varies considerably among different populations. The aim of EPISER2016 study was to estimate the prevalence of RA in the general adult population in Spain. We designed a population-based cross-sectional study. A national survey was conducted between November 2016 and October 2017 involving a probabilistic sample from the general population aged 20 years or older. Subjects were randomly selected for phone screening using a computer-assisted telephone interviewer system. Positive RA screening results were evaluated by a rheumatologist. Cases fulfilled the 1987 ACR and/or the 2010 ACR/EULAR criteria; previous diagnosis established by a rheumatologist and clearly identified in medical records were also accepted regardless of the criteria used. Prevalence estimates with 95% CI were calculated taking into account the design of the sample (weighting based on age, sex, and geographic origin using as a reference the distribution of the population in Spain). 4916 subjects participated in the study and 39 RA cases were confirmed. RA estimated prevalence was 0.82% (95% CI 0.59-1.15). Mean age of RA cases was 60.48 (14.85) years, they were more frequently women (61.5%), from urban areas (74.4%), non-smokers (43.6%), and with a high body mass index (53.8% with overweight). Extrapolating to the population in Spain (approximately 37 million are ≥ 20 years old), it was estimated that there were between 220,000 and 430,000 people aged 20 years or older with RA. No undiagnosed cases were detected, which could be related to the establishment of early arthritis clinics around the country, increasing the rates of diagnosis during early phases of RA.

Identifiants

pubmed: 33299019
doi: 10.1038/s41598-020-76511-6
pii: 10.1038/s41598-020-76511-6
pmc: PMC7725786
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21551

Références

Ann Rheum Dis. 2011 Apr;70(4):624-9
pubmed: 21149495
Joint Bone Spine. 2016 Dec;83(6):625-630
pubmed: 27616690
Arthritis Rheum. 2003 Apr;48(4):917-26
pubmed: 12687533
Rheumatol Int. 2014 May;34(5):659-64
pubmed: 24610538
BMC Res Notes. 2014 Dec 19;7:937
pubmed: 25527187
Scand J Rheumatol. 2008 Mar-Apr;37(2):113-9
pubmed: 18415768
Br J Nurs. 2006 Apr 13-26;15(7):394-9
pubmed: 16723942
J Rheumatol. 2014 Dec;41(12):2352-60
pubmed: 25274894
Ann Epidemiol. 2007 Sep;17(9):643-53
pubmed: 17553702
Bull World Health Organ. 2003;81(9):646-56
pubmed: 14710506
Rheumatol Int. 2017 Sep;37(9):1551-1557
pubmed: 28455559
Ann Rheum Dis. 2010 Sep;69(9):1580-8
pubmed: 20699241
Semin Arthritis Rheum. 2006 Dec;36(3):182-8
pubmed: 17045630
Reumatol Clin. 2019 Mar - Apr;15(2):90-96
pubmed: 28774657
Health Serv Res. 2013 Jun;48(3):913-30
pubmed: 23046097
Rheumatology (Oxford). 2002 Jan;41(1):88-95
pubmed: 11792885
Ann Rheum Dis. 2019 Nov;78(11):1463-1471
pubmed: 31511227
Open Rheumatol J. 2011;5:91-7
pubmed: 22216071
Arthritis Rheum. 2011 Jan;63(1):37-42
pubmed: 20967854
Z Rheumatol. 2016 Oct;75(8):819-827
pubmed: 27120440
Joint Bone Spine. 2009 Oct;76(5):497-500
pubmed: 19767228
J Autoimmun. 2010 Aug;35(1):10-4
pubmed: 20080387
Clin Rheumatol. 2017 Dec;36(12):2667-2671
pubmed: 28828712
Rheumatol Int. 2013 Apr;33(4):955-8
pubmed: 22833240
Rheumatol Int. 2014 May;34(5):649-58
pubmed: 24292809
Arthritis Rheum. 2010 Jun;62(6):1576-82
pubmed: 20191579
Arthritis Rheum. 1988 Mar;31(3):315-24
pubmed: 3358796
Ann Rheum Dis. 2005 Oct;64(10):1431-5
pubmed: 15817661
Ann Rheum Dis. 2012 Mar;71(3):363-8
pubmed: 21989539
Rheumatology (Oxford). 2011 Jan;50(1):110-6
pubmed: 20663815
Rheumatology (Oxford). 2010 Aug;49(8):1563-9
pubmed: 20444855
Ann Rheum Dis. 2001 Nov;60(11):1040-5
pubmed: 11602475
J Clin Rheumatol. 2010 Oct;16(7):317-21
pubmed: 20859227
Clin Exp Rheumatol. 2013 May-Jun;31(3):443-51
pubmed: 23415051
Rheumatol Int. 2019 Mar;39(3):541-549
pubmed: 30656412

Auteurs

Lucía Silva-Fernández (L)

Rheumatology Department, Complexo Hospitalario Universitario de A Coruña, As Xubias 84, 15006, A Coruña, Spain. luciasilva@ser.es.

Cristina Macía-Villa (C)

Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain.

Daniel Seoane-Mato (D)

Research Unit, Spanish Society of Rheumatology, Madrid, Spain.

Raúl Cortés-Verdú (R)

Rheumatology, Hospital General de Ontinyent, Ontinyent, Valencia, Spain.

Antonio Romero-Pérez (A)

Rheumatology, Complejo Hospitalario de Jaén, Jaén, Spain.

Víctor Quevedo-Vila (V)

Rheumatology, Hospital Comarcal Monforte de Lemos, Monforte de Lemos, Lugo, Spain.

Dolores Fábregas-Canales (D)

Rheumatology, Hospital de Barbastro, Barbastro, Huesca, Spain.

Fred Antón-Pagés (F)

Rheumatology, Complejo Asistencial Universitario de Palencia, Palencia, Spain.

Gustavo Añez (G)

Rheumatology, Hospital Universitario Puerta del Mar, Cádiz, Spain.

Anahy Brandy (A)

Rheumatology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.

Cristina Martínez-Dubois (C)

Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain.

Paula Rubio-Muñoz (P)

Rheumatology, Hospital Universitari Germans Trias I Pujol, Badalona, Barcelona, Spain.

Carlos Sánchez-Piedra (C)

Research Unit, Spanish Society of Rheumatology, Madrid, Spain.

Federico Díaz-González (F)

Universidad de La Laguna, La Laguna, Santa Cruz de Tenerife, Spain.
Rheumatology, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.

Sagrario Bustabad-Reyes (S)

Rheumatology, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH